4.8 Article

Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis

Journal

GUT
Volume 62, Issue 2, Pages 310-316

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2011-301008

Keywords

-

Funding

  1. Deutsche Forschungsgemeinschaft [VE: KFO210, SFB-TR17]
  2. LOEWE-Schwerpunkt 'Tumour and Inflammation'
  3. Max-Eder program of the German Cancer Research Foundation [VE: 70-3022-El I]
  4. Novartis Foundation
  5. Schulze Center for Novel Therapeutics
  6. Mayo Clinic Cancer Center
  7. National Institutes of Health [CA136526]
  8. Mayo Clinic Pancreatic SPORE [P50 CA102701]
  9. Mayo Clinic Center for Cell Signalling in Gastroenterology [P30 DK84567]

Ask authors/readers for more resources

Transcription factors are proteins that regulate gene expression by modulating the synthesis of messenger RNA. Since this process is often one dominant control point in the production of many proteins, transcription factors represent the key regulators of numerous cellular functions, including proliferation, differentiation and apoptosis. Pancreatic cancer progression is characterised by activation of inflammatory signalling pathways converging on a limited set of transcription factors that fine-tune gene expression patterns contributing to the growth and maintenance of these tumours. Thus strategies targeting these transcriptional networks activated in pancreatic cancer cells could block the effects of upstream inflammatory responses participating in pancreatic tumorigenesis. The authors review this field of research and summarise current strategies for targeting oncogenic transcription factors and their activating signalling networks in the treatment of pancreatic cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available